Assessment of PKA and PKC inhibitors on force and kinetics of non-failing and failing human myocardium

Keyphrases

• Human Myocardium 100%
• PKC Inhibitor 100%
• GF109203X 66%
• H-89 66%
• United States 33%
• Cardiac Function 33%
• Left Ventricular Function 33%
• Protein Kinase 33%
• Human Studies 33%
• Human Heart 33%
• Heart Disease 33%
• Statistical Analysis 33%
• Heart Failure 33%
• Kinetic Parameters 33%
• Protein Kinase Inhibitors 33%
• Time-to-treatment 33%
• Time of Concentration 33%
• Causes of Hospitalization 33%
• Cardiac Contractility 33%
• Prevalent Diseases 33%
• Contractile Force 33%
• Direct Impact 33%
• Ventricular Trabeculation 33%
• Force Parameters 33%
• Contractile Kinetics 33%

Medicine and Dentistry

• Myocardium 100%
• H-89 100%
• Disease 50%
• Heart Function 50%
• Human Study 50%
• Heart Failure 50%
• Heart Disease 50%
• Ex Vivo 50%
• Protein Kinases 50%
• Protein Kinase Inhibitor 50%
• Contractile Function 50%
• Trabecula 50%
• Dimethyl Sulfoxide 50%

Pharmacology, Toxicology and Pharmaceutical Science

• H-89 100%
• Disease 50%
• Human Study 50%
• Heart Disease 50%
• Protein Kinase Inhibitor 50%
• Protein Kinases 50%
• Heart Failure 50%
• Dimethyl Sulfoxide 50%